Alnylam Pharmaceuticals, Inc.
DE ˙ XTRA ˙ US02043Q1076
251,80 € ↑6,70 (2,73%)
2026-06-03
AKTIENPREIS
SecurityDE:DUL / Alnylam Pharmaceuticals, Inc.
InstitutionIMC-Chicago, LLC
IMC-Chicago, LLC ownership in DUL / Alnylam Pharmaceuticals, Inc.

IMC-Chicago, LLC has a history of taking positions in derivatives of the underlying security (DUL) in the form of stock options. The firm currently holds call options representing 30,600 of underlying shares valued at $10,124,622 USD and put options representing 18,100 of underlying shares valued at $5,988,747 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:DUL / Alnylam Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-05 2026-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 30,600 -6.99 10,125 -22.61 n/a n/a n/a
2026-01-29 2025-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 32,900 32.66 13,083 15.69 n/a n/a n/a
2025-11-04 2025-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 24,800 53.09 11,309 114.09 n/a n/a n/a
2025-07-22 2025-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 16,200 -23.94 5,283 -8.16 n/a n/a n/a
2025-04-14 2025-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 21,300 5,751 n/a n/a n/a
2023-04-24 2022-12-31 13F/A ALNYLAM PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-09 2022-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 0 0 n/a n/a n/a
2022-11-08 2022-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 10,200 2,042 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-05 2026-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 18,100 -36.93 5,989 -47.53 n/a n/a n/a
2026-01-29 2025-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 28,700 0.00 11,413 -12.80 n/a n/a n/a
2025-11-04 2025-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 28,700 95.24 13,087 173.04 n/a n/a n/a
2025-07-22 2025-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 14,700 -29.33 4,794 -14.65 n/a n/a n/a
2025-04-14 2025-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 20,800 5,616 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.